Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity

Parasitic infections are a major source of human suffering, mortality, and economic loss, but drug development for these diseases has been stymied by the significant expense involved in bringing a drug though clinical trials and to market. Identification of single compounds active against multiple p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrenkaufer, Gretchen, Li, Pengyang, Stebbins, Erin E., Kangussu-Marcolino, Monica M., Debnath, Anjan, White, Corin V., Moser, Matthew S., DeRisi, Joseph, Gisselberg, Jolyn, Yeh, Ellen, Wang, Steven C., Company, Ana Hervella, Monti, Ludovica, Caffrey, Conor R., Huston, Christopher D., Wang, Bo, Singh, Upinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112225/
https://www.ncbi.nlm.nih.gov/pubmed/32196500
http://dx.doi.org/10.1371/journal.pntd.0008150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112225/
https://www.ncbi.nlm.nih.gov/pubmed/32196500
http://dx.doi.org/10.1371/journal.pntd.0008150

Ejemplares similares